{
      "brief_title": [
            "study",
            "evaluate",
            "safety",
            "tolerability",
            "woman"
      ],
      "brief_summary": [
            "study",
            "ass",
            "safety",
            "tolerability",
            "evaluate",
            "treat",
            "woman",
            "postmenopausal",
            "osteoporosis"
      ],
      "condition": [
            "osteoporosis"
      ],
      "intervention_type": [
            "Drug",
            "Drug"
      ],
      "intervention_name": [
            "MK0217, alendronate sodium/Duration of Treatment: 6 months",
            "Comparator: placebo / Duration of Treatment: 6 months"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "woman",
            "postmenopausal",
            "osteoporosis",
            "exclusion",
            "criterion",
            "high",
            "risk",
            "fracture",
            "esophageal",
            "abnormality",
            "upper",
            "gastrointestinal",
            "symptom",
            "relieve",
            "medication",
            "metabolic",
            "bone",
            "disease",
            "example",
            "vitamin",
            "deficiency",
            "medication",
            "would",
            "affect",
            "breakdown",
            "bone"
      ],
      "gender": "Female",
      "minimum_age": [
            "25",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "mesh_term": [
            "postmenopausal"
      ],
      "id": "NCT00092027"
}